bendamustine hydrochloride has been researched along with yttrium radioisotopes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alhaj Moustafa, M; Borah, BJ; Cerhan, JR; Dholakia, R; Hoppe, BS; Jiang, L; Li, K; Moriarty, JP; Peterson, J; Tun, HW; Witzig, TE | 1 |
1 other study(ies) available for bendamustine hydrochloride and yttrium radioisotopes
| Article | Year |
|---|---|
Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine + Rituximab in Low-grade Lymphomas.
Topics: Bendamustine Hydrochloride; Cost-Benefit Analysis; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Radioimmunotherapy; Rituximab; Yttrium Radioisotopes | 2023 |